BRSF — Brain Scientific Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
- $0.00m
- $2.02m
- $0.21m
Annual balance sheet for Brain Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.164 | 0.261 | 0.273 | 0.785 | 0.748 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0.006 | 0.001 | 0.017 | 0.001 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.178 | 0.289 | 0.44 | 1.13 | 1.31 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.002 | 0.002 | 0 | 0.315 | 0.209 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.18 | 0.291 | 0.44 | 13.4 | 11.7 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.227 | 1.19 | 5.21 | 4.01 | 7.42 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.234 | 1.19 | 5.24 | 14.1 | 7.43 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.054 | -0.896 | -4.8 | -0.695 | 4.32 |
| Total Liabilities & Shareholders' Equity | 0.18 | 0.291 | 0.44 | 13.4 | 11.7 |
| Total Common Shares Outstanding |